about
The cost of inpatient care of schizophrenia in the Polish and Ukrainian academic centers--Poznan and LvivAffordability of medicines in the European UnionThe Cost of Inpatient Care of Schizophrenia and Treatment Schedules Used in German Academic Center: Kiel.Costs of treatment of adult patients with cystic fibrosis in Poland and internationally.Conventional or Natural Pharmacotherapy and the Prevalence of Anxiety and Depression During Menopause.Misuse of OTC drugs in Poland.Effect of combined administration of aripiprazole and fluoxetine on cognitive functions in female rats exposed to ethyl alcohol.The influence of aripiprazole and olanzapine on neurotransmitters level in frontal cortex of prenatally stressed rats.Schizophrenia and Employment: Evaluation From Professionals Point of View.The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016.Correction: The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016Feasibility of Atrial Fibrillation Screening With Mobile Health Technologies at PharmaciesAnalysis of pharmacotherapy regimen and costs in patients with drug-resistant epilepsy following vagus nerve stimulation therapy: a single-center study (Poland)Costs of inpatient care of depression in 2014 in Polish (Poznan) and German (Kiel) hospitalSafety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process
P50
Q35182685-CB5C8FE8-0EA7-4665-80B6-1384786937CAQ36291455-6A80E947-7863-46D2-883A-1AE4D63F353CQ37306488-86AE06AC-C0E6-4A20-9CA1-67188282153FQ38731036-0508EAE4-A87A-493D-B4AA-DDE1BBBB169AQ39158130-F94DB67B-A168-4821-8444-8AA9BC32873CQ39655204-E43F97E9-0A4C-495E-82DB-71EAE68FF801Q47803360-D38FDB78-179A-41CE-A983-3351EBB2C380Q47973590-CCF0BBA5-F7AD-4FDE-A8A1-CCB43ACB58B4Q50952598-6AB2C879-A33D-459C-87EF-32CA025824D5Q55261175-364D2A66-BDB1-44CC-8037-A1A33AD130E3Q89567799-64A1E723-BFE2-4FE3-B933-7675E1100A6DQ90439246-265CB2F3-C1FF-4035-8682-154B00B45321Q91265268-A589EE2A-81B0-4336-ABB2-D72A93732D8CQ92152595-E4F99801-0B34-419A-B63A-3C23F5792ECDQ92425743-FA3C51D8-97B8-40AD-AA00-940AB4A28DE9
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tomasz Zaprutko
@ast
Tomasz Zaprutko
@en
Tomasz Zaprutko
@es
Tomasz Zaprutko
@nl
type
label
Tomasz Zaprutko
@ast
Tomasz Zaprutko
@en
Tomasz Zaprutko
@es
Tomasz Zaprutko
@nl
prefLabel
Tomasz Zaprutko
@ast
Tomasz Zaprutko
@en
Tomasz Zaprutko
@es
Tomasz Zaprutko
@nl
P106
P31
P496
0000-0001-9737-9624